Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.17%) 5 336.50 points
Dow Jones Futures
(0.08%) 40 171 points
Nasdaq Futures
(0.26%) 18 684 points
Oil
(-0.64%) $79.55
Gas
(2.63%) $2.70
Gold
(0.22%) $2 422.70
Silver
(0.83%) $31.52
Platinum
(-2.09%) $1 067.20
USD/EUR
(0.16%) $0.921
USD/NOK
(0.26%) $10.70
USD/GBP
(0.07%) $0.788
USD/RUB
(-0.40%) $90.60

Realtime updates for MabCure, Inc. [MBCI]

Exchange: OTC Sector: Technology Industry: Solar
Last Updated16 May 2024 @ 15:10
25% discount on Stockinvest.us - Use code: Podcast

-93.75% $ 0.0000010

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 15:10):

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer...

Stats
Today's Volume 300.00
Average Volume 40.00
Market Cap 32 182.00
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2011-05-19 Berdugo Gad Buy 200 000 Stock Option (Right to Buy)
2011-09-24 Berdugo Gad Sell 120 000 Stock Option (Right to Buy)
2008-07-07 Katz Steven Buy 0
INSIDER POWER
0.00
Last 2 transactions
Buy: 200 000 | Sell: 120 000

MabCure, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MabCure, Inc. Financials

Annual 2011
Revenue: $500 000
Gross Profit: $500 000 (100.00 %)
EPS: $-0.198
FY 2011
Revenue: $500 000
Gross Profit: $500 000 (100.00 %)
EPS: $-0.198
FY 2010
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0200

Financial Reports:

No articles found.

MabCure, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

MabCure, Inc.

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators